Literature DB >> 28133992

The family impact of caring for a child with juvenile dermatomyositis.

Samantha Kountz-Edwards1, Christa Aoki1, Caitlin Gannon1, Rowena Gomez1, Matthew Cordova1, Wendy Packman1.   

Abstract

Background Juvenile dermatomyositis (JDM), a rare autoimmune disease, accounts for more than 80% of idiopathic inflammatory myopathy childhood cases, making it the most common idiopathic inflammatory myopathy among children. The average age of onset is approximately 7 years and commonly leads a chronic course. Symptoms of JDM include cutaneous features (Gottron's rash, heliotrope rash, or nail fold capillary changes), musculoskeletal features, calcinosis and lipodystrophy (a symmetrical deficit of subcutaneous fatty tissue), and acanthosis (thickening of the skin). Despite improvement in treatment regimens and the lowering of mortality rates, some children still lose their lives to JDM. This study assessed the effects of caring for a child diagnosed with JDM on the family system. Methods Participants included 36 mothers and 3 fathers of a child diagnosed with JDM. Parents were administered self-report measures, which assessed the overall family functioning (PedsQL-Family Impact Module), and the parents' mood and level of distress (profile of mood states). Additionally, parents were administered a semi-structured interview that included background information, psychosocial information, and sources of support. Results and conclusion Families of children with JDM reported difficulties in family functioning, communication problems, and an increased number of conflicts. Parents appeared to be experiencing higher than average levels of worry, worse physical functioning, and family relationships when compared to normative populations. Parents would benefit from psychosocial support due to the many challenges associated with caring for a child with JDM.

Entities:  

Keywords:  Juvenile dermatomyositis; family; parent/caregiver mood and stress

Mesh:

Year:  2017        PMID: 28133992     DOI: 10.1177/1742395317690034

Source DB:  PubMed          Journal:  Chronic Illn        ISSN: 1742-3953


  7 in total

Review 1.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

2.  Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain.

Authors:  Maria de Fátima Rodrigues Diniz; Katia Tomie Kozu; Adriana Maluf Elias; Alessandro Cavalcanti Lianza; Karen Saori Shiraishi Sawamura; Carolina Rocha Brito Menezes; Juliana Caires de Oliveira Achili Ferreira; Clovis Artur Silva; Gabriela Nunes Leal
Journal:  Clin Rheumatol       Date:  2020-09-28       Impact factor: 2.980

3.  Being on the juvenile dermatomyositis rollercoaster: a qualitative study.

Authors:  Polly Livermore; Suzanne Gray; Kathleen Mulligan; Jennifer N Stinson; Lucy R Wedderburn; Faith Gibson
Journal:  Pediatr Rheumatol Online J       Date:  2019-06-18       Impact factor: 3.054

4.  Mapping the current psychology provision for children and young people with juvenile dermatomyositis.

Authors:  Polly Livermore; Faith Gibson; Kathleen Mulligan; Lucy R Wedderburn; Liza J McCann; Suzanne Gray
Journal:  Rheumatol Adv Pract       Date:  2021-09-10

5.  Caregiver health-related quality of life 1 year following pediatric gastrostomy tube placement.

Authors:  Karlie O'Brien; Jack Scaife; Stephanie Iantorno; Brian Bucher
Journal:  Surg Open Sci       Date:  2022-08-18

6.  Parent Perspectives on Addressing Emotional Health for Children and Young Adults With Juvenile Myositis.

Authors:  Kaveh Ardalan; Oluwatosin Adeyemi; Dawn M Wahezi; Anne E Caliendo; Megan L Curran; Jessica Neely; Susan Kim; Colleen K Correll; Emily J Brunner; Andrea M Knight
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11-27       Impact factor: 4.794

7.  A brief version of the Pediatric Inventory for Parents (PIP) in Spanish population: Stress of main family carers of chronic paediatric patients.

Authors:  Sara Casaña-Granell; Laura Lacomba-Trejo; Selene Valero-Moreno; Vicente Prado-Gasco; Inmaculada Montoya-Castilla; Marián Pérez-Marín
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.